Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
IPO News

| More

Vadodara-based Shiva Pharmachem Limited files DRHP with SEBI for its Rs 900 Crore IPO

Posted On: 2023-08-22 20:01:55 (Time Zone: IST)


Vadodara-based Shiva Pharmachem, the largest manufacturer of acid and alkyl chlorides, by volume, in CY 2022 in India and a key player globally, with over 2 decades of experience in the Indian specialty chemicals business has filed its Draft Red Herring prospectus (DRHP) with capital market regulator Sebi to raise funds through for its initial public offering (IPO).

The IPO with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by Promoter and Promoter Group Selling Shareholders.

The offer for sale comprises of up to Rs 383 crore by Vishal Rakesh Agrawal, up to Rs 383 crore by Rahul Rakesh Agrawal, and up to Rs 134 crore by Geetganga Investment Private Limited.

The Offer is being made through the Book Building Process, wherein not more than 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers, not less than 15% of the Offer shall be available for allocation to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders.

Led by its founders Mr. Rakesh Agrawal (Non-Executive Chairman), Mr. Vishal Agrawal (Managing Director), and Mr. Rahul Agrawal (Non-Executive Director), Shiva Pharmachem established its business in 1999 and has over twenty years of experience in the chemical industry. As at FY23, it serves over 181 multinational and domestic companies across 22 countries. Its prominent markets include Germany, the United States, Switzerland, Italy, and Mexico.

The company commenced its operations centered around chlorine chemistry, particularly specializing in the chlorination of acids and alcohols using thionyl chloride. Gradually, expanded its capabilities to encompass intricate chemistry involving advanced intermediates and multi-step processes, often comprising 4 to 5 steps.Its manufacturing facilities located in Luna (Gujarat), Dahej SEZ (Gujarat), and Sajóbábony (Hungary). The Hungarian plant stands out notably with cutting-edge phosgenation capabilities, specializing in phosgene-based intermediates.

Its product lines encompass a broad spectrum, including aliphatic and aromatic chlorides, aliphatic and aromatic nitriles, alkoxy ketones, herbicide safeners, thiocarbamates, chloroformates, and isocyanates. These versatile products find applications across diverse sectors such as agrochemicals, performance materials, disinfectants, pharmaceuticals, polymer and cosmetics besides others.

Over 80% of its revenue from operations in FY 23 originated from Fortune 500 companies worldwide. Its clients include DuPont Specialty Products USA LLC, Godrej Agrovet Limited, Nouryon Functional Chemicals B.V., Reckitt Benckiser (India) Private Limited, SRF Limited, and Syngenta Crop Protection AG.

Shiva Pharmachem competes with firms which includes Navin Fluorine International Limited, Clean Science and Technology Limited, and Aether Industries Limited.

For the fiscal year 2023, the consolidated revenue from operations increased 6.25% to Rs 1,079.47 crore against Rs 1,015.99 crore a year ago, primarily attributed to increase in revenue from sales of products. Net profit increased by 40% from Rs 83.32 crore in fiscal 2022 to Rs 116.65 crore in fiscal 2023.

India's strong position is evident in its chemical exports, ranking 14th globally in exports by value in CY2022. Conversely, the nation is a notable importer of chemicals, securing the 8th rank globally by value in CY2022, as per the F&S Report published in August 2023.

JM Financial Limited, and Kotak Mahindra Capital Company Limited are the book running lead managers and Link Intime India Private Limited is the registrar to the offer. The equity shares are proposed to be listed on BSE and NSE.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Icon Facilitators Announces BSE SME IPO Approval, Targets ?22 Crore Fundraise

Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO

Leading Decorative Wall Panel & Premium Laminates Brand Euro Pratik files DRHP for Rs 730 crore IPO

P S Raj Steels Receives In-Principal Approval for IPO on NSE Emerge

Jesons Industries refiles DRHP with Sebi for IPO

Standard Glass Lining Technology Limited raises Rs 123 crores from Anchor Investors

Greaves Electric Mobility Limited files DRHP for IPO

Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2

Senores Pharmaceuticals IPO fully subscribed on Day 1

Speciality Fabric Manufacturer Rachit Prints files DRHP with BSE SME

Eleganz Interiors Limited files DRHP with NSE Emerge

Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO

Afcons Infrastructure Ltd's IPO to open on Friday, October 25, 2024, price band set at ₹440/- to ₹463/- per Equity Share

Senores Pharmaceuticals gets Sebi nod for IPO

Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO

Dr. Agarwal's Health Care files DRHP for IPO

Icon Facilitators Limited files DRHP with BSE SME

Casagrand Premier Builder Limited files DRHP for Rs 1,100 crore IPO

Manba Finance Limited raises Rs. 45.25 crore from Anchor Investors

NTPC Green Energy Ltd files DRHP for IPO

Influx Healthtech Limited Files DRHP with NSE Emerge

Gala Precision Engineering IPO subscribed 201.41 times on Final Day, the most since the start of FY25

Identical Brains Studios Limited files DRHP with NSE Emerge

Gala Precision Engineering Ltd's IPO to open on Monday, September 02, 2024, price band set at ?503/- to ?529/- per Equity Share

Sanstar Limited IPO subscribed 82.98 times on Final Day

Sanstar Ltd's IPO to open on Friday, July 19, 2024, price band set at ?90/- to ?95/- per Equity Share

Three M Paper Boards Ltd's SME IPO to open on Friday, July 12, 2024

Virtual Galaxy Infotech attracts marquee investors, raises Rs 21.44 Crore ahead of IPO Launch

IT Solutions provider Orient Technologies gets Sebi nod for IPO

Accel and Flipkart-backed Zinka Logistics Solutions Limited files DRHP for IPO

Sleepwear-focused company S D Retail Limited files DRHP for SME IPO

ACME Solar Holdings Limited files DRHP for Rs 3,000 crore IPO

Nephro Care India Makes History - First SME IPO to Surpass Rs. 20,000 Crore in bids

Gala Precision Engineering gets Sebi nod for IPO

Noida-based Interarch Building Products Limited gets SEBI nod for IPO

Shivalik Engineering Industries Limited files DRHP for IPO

Niva Bupa files for Rs 3,000Cr IPO

Sagility India Limited files DRHP for IPO

Ambey Laboratories Ltd IPO to open for subscription on July 4, 2024

Nephro Care India Limited IPO opened today, Anchor Book fully subscribed

Allied Blenders & Distillers IPO subscribed 23.49 times on Final Day

Allied Blenders & Distillers IPO fully subscribed on Day 2

Allied Blenders & Distillers IPO subscribed 51% on Day 1

Stanley Lifestyles IPO subscribed 95.75 times on Final Day

Deepak Parekh-backed Nephro Care India Limited's IPO opens on Friday, June 28

Allied Blenders & Distillers Limited raises Rs. 449.1 crore from Anchor Investors

Stanley Lifestyles IPO subscribed 5.22 times on Day 2

Mason Infratech Limited IPO Opens on June 24, 2024

Stanley Lifestyles IPO fully subscribed on Day 1 led by strong retail, NII demand

Stanley Lifestyles Limited raises Rs. 161.10 crore from Anchor Investors


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020